Cargando…

Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma

BACKGROUND: As one of the key criteria to differentiate benign vs. malignant tumors in ovarian and other solid cancers, tumor-stroma reaction (TSR) is long observed by pathologists and has been found correlated with patient prognosis. However, paucity of study aims to overcome subjective bias or aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jun, Tekin, Burak, Yuan, Lin, Armasu, Sebastian, Winham, Stacey J., Goode, Ellen L., Liu, Hongfang, Huang, Yajue, Guo, Ruifeng, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490262/
https://www.ncbi.nlm.nih.gov/pubmed/36160147
http://dx.doi.org/10.3389/fmed.2022.994467
_version_ 1784793048940544000
author Jiang, Jun
Tekin, Burak
Yuan, Lin
Armasu, Sebastian
Winham, Stacey J.
Goode, Ellen L.
Liu, Hongfang
Huang, Yajue
Guo, Ruifeng
Wang, Chen
author_facet Jiang, Jun
Tekin, Burak
Yuan, Lin
Armasu, Sebastian
Winham, Stacey J.
Goode, Ellen L.
Liu, Hongfang
Huang, Yajue
Guo, Ruifeng
Wang, Chen
author_sort Jiang, Jun
collection PubMed
description BACKGROUND: As one of the key criteria to differentiate benign vs. malignant tumors in ovarian and other solid cancers, tumor-stroma reaction (TSR) is long observed by pathologists and has been found correlated with patient prognosis. However, paucity of study aims to overcome subjective bias or automate TSR evaluation for enabling association analysis to a large cohort. MATERIALS AND METHODS: Serving as positive and negative sets of TSR studies, H&E slides of primary tumors of high-grade serous ovarian carcinoma (HGSOC) (n = 291) and serous borderline ovarian tumor (SBOT) (n = 15) were digitally scanned. Three pathologist-defined quantification criteria were used to characterize the extents of TSR. Scores for each criterion were annotated (0/1/2 as none-low/intermediate/high) in the training set consisting of 18,265 H&E patches. Serial of deep learning (DL) models were trained to identify tumor vs. stroma regions and predict TSR scores. After cross-validation and independent validations, the trained models were generalized to the entire HGSOC cohort and correlated with clinical characteristics. In a subset of cases tumor transcriptomes were available, gene- and pathway-level association studies were conducted with TSR scores. RESULTS: The trained models accurately identified the tumor stroma tissue regions and predicted TSR scores. Within tumor stroma interface region, TSR fibrosis scores were strongly associated with patient prognosis. Cancer signaling aberrations associated 14 KEGG pathways were also found positively correlated with TSR-fibrosis score. CONCLUSION: With the aid of DL, TSR evaluation could be generalized to large cohort to enable prognostic association analysis and facilitate discovering novel gene and pathways associated with disease progress.
format Online
Article
Text
id pubmed-9490262
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94902622022-09-22 Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma Jiang, Jun Tekin, Burak Yuan, Lin Armasu, Sebastian Winham, Stacey J. Goode, Ellen L. Liu, Hongfang Huang, Yajue Guo, Ruifeng Wang, Chen Front Med (Lausanne) Medicine BACKGROUND: As one of the key criteria to differentiate benign vs. malignant tumors in ovarian and other solid cancers, tumor-stroma reaction (TSR) is long observed by pathologists and has been found correlated with patient prognosis. However, paucity of study aims to overcome subjective bias or automate TSR evaluation for enabling association analysis to a large cohort. MATERIALS AND METHODS: Serving as positive and negative sets of TSR studies, H&E slides of primary tumors of high-grade serous ovarian carcinoma (HGSOC) (n = 291) and serous borderline ovarian tumor (SBOT) (n = 15) were digitally scanned. Three pathologist-defined quantification criteria were used to characterize the extents of TSR. Scores for each criterion were annotated (0/1/2 as none-low/intermediate/high) in the training set consisting of 18,265 H&E patches. Serial of deep learning (DL) models were trained to identify tumor vs. stroma regions and predict TSR scores. After cross-validation and independent validations, the trained models were generalized to the entire HGSOC cohort and correlated with clinical characteristics. In a subset of cases tumor transcriptomes were available, gene- and pathway-level association studies were conducted with TSR scores. RESULTS: The trained models accurately identified the tumor stroma tissue regions and predicted TSR scores. Within tumor stroma interface region, TSR fibrosis scores were strongly associated with patient prognosis. Cancer signaling aberrations associated 14 KEGG pathways were also found positively correlated with TSR-fibrosis score. CONCLUSION: With the aid of DL, TSR evaluation could be generalized to large cohort to enable prognostic association analysis and facilitate discovering novel gene and pathways associated with disease progress. Frontiers Media S.A. 2022-09-07 /pmc/articles/PMC9490262/ /pubmed/36160147 http://dx.doi.org/10.3389/fmed.2022.994467 Text en Copyright © 2022 Jiang, Tekin, Yuan, Armasu, Winham, Goode, Liu, Huang, Guo and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Jiang, Jun
Tekin, Burak
Yuan, Lin
Armasu, Sebastian
Winham, Stacey J.
Goode, Ellen L.
Liu, Hongfang
Huang, Yajue
Guo, Ruifeng
Wang, Chen
Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title_full Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title_fullStr Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title_full_unstemmed Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title_short Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
title_sort computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490262/
https://www.ncbi.nlm.nih.gov/pubmed/36160147
http://dx.doi.org/10.3389/fmed.2022.994467
work_keys_str_mv AT jiangjun computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT tekinburak computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT yuanlin computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT armasusebastian computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT winhamstaceyj computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT goodeellenl computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT liuhongfang computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT huangyajue computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT guoruifeng computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma
AT wangchen computationaltumorstromareactionevaluationledtonovelprognosisassociatedfibrosisandmolecularsignaturediscoveriesinhighgradeserousovariancarcinoma